ProQR Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for ProQR Therapeutics stock have an average target of 8.50, with a low estimate of 2.00 and a high estimate of 14. The average target predicts an increase of 415.15% from the current stock price of 1.65.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.00	$8.50	$11	$14
Change	+21.21%	+415.15%	+566.67%	+748.48%

Analyst Ratings

The average analyst rating for ProQR Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	3	3	3	3	4	4
Buy	0	0	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	5	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+142.42%	Mar 14, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $10 → $12	Strong Buy	Maintains	$10 → $12	+627.27%	Mar 14, 2025
Catherine Novack Jones Trading	Jones Trading	Strong Buy Initiates $11	Strong Buy	Initiates	$11	+566.67%	Feb 12, 2025
Jonathan Wolleben JMP Securities	JMP Securities	Buy Reiterates $8	Buy	Reiterates	$8	+384.85%	Dec 12, 2024
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $4	Strong Buy	Maintains	$4	+142.42%	Dec 12, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

27.25M

from 19.55M

39.44%

from 19.55M

Revenue Next Year

10.81M

from 27.25M

-60.33%

from 27.25M

EPS This Year

-0.41

from -0.32

EPS Next Year

-0.54

from -0.41

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.03M	2.38M	4.36M	6.59M	19.55M	27.25M	10.81M	14.69M
Revenue Growth	-46.77%	131.10%	83.31%	51.27%	196.41%	39.44%	-60.33%	35.88%
EPS	-0.93	-0.95	-0.90	-0.35	-0.32	-0.41	-0.54	-
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	8	4

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	64.6M	20.0M	16.3M
Avg	27.3M	10.8M	14.7M
Low	n/a	n/a	13.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	230.4%	-26.8%	50.7%
Avg	39.4%	-60.3%	35.9%
Low	-	-	20.4%

EPS Forecast

EPS	2025	2026
High	-0.17	-0.38
Avg	-0.41	-0.54
Low	-0.59	-0.67

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.